Doug Kerr
Tracked across 2 events · 12 articles · First seen Jun 03, 2026 · Last active Jul 28, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Doug Kerr, Dyne's chief medical officer, commented on the potential of DYNE-302, highlighting the advantages of the FORCE platform.
Jul 28, 2026 · 6 articles
Business
Impact: Doug Kerr, Chief Medical Officer of Dyne Therapeutics, provided commentary on the significance of completing enrollment in the ACHIEVE trial, highlighting the potential for zeleciment basivarsen as a best-in-class therapy.
Jun 03, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Doug Kerr live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard